Bromine in PDB 8eo2: Lufaxin A Bifunctional Inhibitor of Complement and Coagulation
Protein crystallography data
The structure of Lufaxin A Bifunctional Inhibitor of Complement and Coagulation, PDB code: 8eo2
was solved by
J.F.Andersen,
E.C.Strayer,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
42.18 /
2.31
|
Space group
|
P 21 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
64.48,
71.31,
167.32,
90,
90,
90
|
R / Rfree (%)
|
20.1 /
25.5
|
Bromine Binding Sites:
The binding sites of Bromine atom in the Lufaxin A Bifunctional Inhibitor of Complement and Coagulation
(pdb code 8eo2). This binding sites where shown within
5.0 Angstroms radius around Bromine atom.
In total 5 binding sites of Bromine where determined in the
Lufaxin A Bifunctional Inhibitor of Complement and Coagulation, PDB code: 8eo2:
Jump to Bromine binding site number:
1;
2;
3;
4;
5;
Bromine binding site 1 out
of 5 in 8eo2
Go back to
Bromine Binding Sites List in 8eo2
Bromine binding site 1 out
of 5 in the Lufaxin A Bifunctional Inhibitor of Complement and Coagulation
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 1 of Lufaxin A Bifunctional Inhibitor of Complement and Coagulation within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Br503
b:78.8
occ:1.00
|
NZ
|
A:LYS117
|
2.7
|
59.7
|
1.0
|
N
|
A:GLU186
|
3.6
|
56.1
|
1.0
|
CG
|
A:ARG185
|
3.8
|
79.2
|
1.0
|
CA
|
A:ARG185
|
3.9
|
64.2
|
1.0
|
O
|
A:GLU186
|
4.0
|
53.2
|
1.0
|
CG
|
A:GLU186
|
4.1
|
58.7
|
1.0
|
CE
|
A:LYS117
|
4.2
|
68.7
|
1.0
|
O
|
A:ALA184
|
4.3
|
63.1
|
1.0
|
C
|
A:ARG185
|
4.3
|
58.5
|
1.0
|
CB
|
A:ARG185
|
4.4
|
67.2
|
1.0
|
CD
|
A:ARG185
|
4.5
|
74.7
|
1.0
|
CA
|
A:GLU186
|
4.6
|
57.6
|
1.0
|
NE
|
A:ARG185
|
4.7
|
72.0
|
1.0
|
C
|
A:GLU186
|
4.8
|
54.3
|
1.0
|
CB
|
A:GLU186
|
4.9
|
53.1
|
1.0
|
OE2
|
A:GLU186
|
4.9
|
61.0
|
1.0
|
N
|
A:ARG185
|
5.0
|
58.7
|
1.0
|
|
Bromine binding site 2 out
of 5 in 8eo2
Go back to
Bromine Binding Sites List in 8eo2
Bromine binding site 2 out
of 5 in the Lufaxin A Bifunctional Inhibitor of Complement and Coagulation
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 2 of Lufaxin A Bifunctional Inhibitor of Complement and Coagulation within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Br504
b:87.7
occ:1.00
|
NE
|
A:ARG119
|
3.3
|
54.8
|
1.0
|
N
|
A:ARG119
|
3.5
|
55.7
|
1.0
|
O
|
A:SER115
|
3.5
|
66.3
|
1.0
|
OD2
|
A:ASP118
|
3.6
|
87.7
|
1.0
|
CA
|
A:PHE116
|
3.7
|
58.6
|
1.0
|
O
|
A:PHE116
|
3.7
|
59.1
|
1.0
|
C
|
A:PHE116
|
3.7
|
57.5
|
1.0
|
CB
|
A:ASP118
|
3.8
|
69.1
|
1.0
|
NH2
|
A:ARG119
|
3.8
|
56.5
|
1.0
|
N
|
A:ASP118
|
3.9
|
62.3
|
1.0
|
CB
|
A:ARG119
|
3.9
|
54.4
|
1.0
|
CZ
|
A:ARG119
|
4.1
|
55.4
|
1.0
|
CG
|
A:ARG119
|
4.1
|
55.0
|
1.0
|
CG
|
A:ASP118
|
4.2
|
83.1
|
1.0
|
CA
|
A:ASP118
|
4.2
|
60.6
|
1.0
|
C
|
A:SER115
|
4.3
|
63.0
|
1.0
|
CD
|
A:ARG119
|
4.3
|
54.9
|
1.0
|
C
|
A:ASP118
|
4.3
|
57.7
|
1.0
|
CA
|
A:ARG119
|
4.3
|
55.6
|
1.0
|
N
|
A:PHE116
|
4.4
|
60.3
|
1.0
|
N
|
A:LYS117
|
4.5
|
62.5
|
1.0
|
CB
|
A:PHE116
|
4.7
|
53.0
|
1.0
|
C
|
A:LYS117
|
4.9
|
63.9
|
1.0
|
CD1
|
A:PHE116
|
4.9
|
56.5
|
1.0
|
|
Bromine binding site 3 out
of 5 in 8eo2
Go back to
Bromine Binding Sites List in 8eo2
Bromine binding site 3 out
of 5 in the Lufaxin A Bifunctional Inhibitor of Complement and Coagulation
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 3 of Lufaxin A Bifunctional Inhibitor of Complement and Coagulation within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Br505
b:86.9
occ:1.00
|
O6
|
C:NAG1
|
3.0
|
47.1
|
1.0
|
NZ
|
A:LYS90
|
3.2
|
52.4
|
1.0
|
N2
|
C:NAG2
|
3.3
|
52.9
|
1.0
|
C6
|
C:NAG1
|
3.7
|
43.9
|
1.0
|
CE
|
A:LYS90
|
3.8
|
43.1
|
1.0
|
C8
|
C:NAG2
|
4.0
|
44.6
|
1.0
|
C2
|
C:NAG2
|
4.1
|
54.2
|
1.0
|
C7
|
C:NAG2
|
4.1
|
49.3
|
1.0
|
C3
|
C:NAG2
|
4.2
|
57.1
|
1.0
|
C1
|
C:NAG2
|
4.2
|
53.9
|
1.0
|
O
|
A:HOH678
|
4.5
|
43.9
|
1.0
|
O3
|
C:NAG2
|
4.7
|
57.3
|
1.0
|
O4
|
C:NAG1
|
4.8
|
51.1
|
1.0
|
CG2
|
A:VAL45
|
4.8
|
43.1
|
1.0
|
OE1
|
A:GLN80
|
4.9
|
49.7
|
1.0
|
C5
|
C:NAG1
|
5.0
|
52.5
|
1.0
|
C4
|
C:NAG1
|
5.0
|
50.5
|
1.0
|
|
Bromine binding site 4 out
of 5 in 8eo2
Go back to
Bromine Binding Sites List in 8eo2
Bromine binding site 4 out
of 5 in the Lufaxin A Bifunctional Inhibitor of Complement and Coagulation
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 4 of Lufaxin A Bifunctional Inhibitor of Complement and Coagulation within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Br302
b:75.3
occ:1.00
|
N
|
B:GLU186
|
3.4
|
47.5
|
1.0
|
NZ
|
B:LYS117
|
3.9
|
60.4
|
1.0
|
O
|
B:GLU186
|
3.9
|
47.0
|
1.0
|
CA
|
B:ARG185
|
3.9
|
55.7
|
1.0
|
CG
|
B:GLU186
|
4.0
|
49.8
|
1.0
|
CE
|
B:LYS117
|
4.1
|
54.4
|
1.0
|
C
|
B:ARG185
|
4.2
|
49.3
|
1.0
|
NE
|
B:ARG185
|
4.2
|
61.2
|
1.0
|
O
|
B:ALA184
|
4.2
|
53.6
|
1.0
|
CD
|
B:ARG185
|
4.3
|
59.0
|
1.0
|
CA
|
B:GLU186
|
4.4
|
53.1
|
1.0
|
CB
|
B:ARG185
|
4.6
|
55.5
|
1.0
|
C
|
B:GLU186
|
4.6
|
47.6
|
1.0
|
CB
|
B:GLU186
|
4.6
|
44.2
|
1.0
|
N
|
B:ARG185
|
5.0
|
45.1
|
1.0
|
CG
|
B:ARG185
|
5.0
|
57.4
|
1.0
|
|
Bromine binding site 5 out
of 5 in 8eo2
Go back to
Bromine Binding Sites List in 8eo2
Bromine binding site 5 out
of 5 in the Lufaxin A Bifunctional Inhibitor of Complement and Coagulation
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 5 of Lufaxin A Bifunctional Inhibitor of Complement and Coagulation within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Br303
b:86.6
occ:1.00
|
NE
|
B:ARG119
|
3.4
|
56.0
|
1.0
|
N
|
B:ARG119
|
3.5
|
58.8
|
1.0
|
O
|
B:SER115
|
3.7
|
64.7
|
1.0
|
NH2
|
B:ARG119
|
3.7
|
52.8
|
1.0
|
CA
|
B:PHE116
|
3.8
|
60.9
|
1.0
|
O
|
B:PHE116
|
3.8
|
56.1
|
1.0
|
C
|
B:PHE116
|
3.8
|
57.0
|
1.0
|
CB
|
B:ARG119
|
3.9
|
54.2
|
1.0
|
CB
|
B:ASP118
|
3.9
|
59.6
|
1.0
|
N
|
B:ASP118
|
4.0
|
60.1
|
1.0
|
CZ
|
B:ARG119
|
4.0
|
58.8
|
1.0
|
CG
|
B:ARG119
|
4.2
|
55.5
|
1.0
|
CA
|
B:ASP118
|
4.3
|
57.4
|
1.0
|
C
|
B:ASP118
|
4.3
|
60.6
|
1.0
|
CA
|
B:ARG119
|
4.3
|
55.9
|
1.0
|
CD
|
B:ARG119
|
4.4
|
49.6
|
1.0
|
C
|
B:SER115
|
4.5
|
61.8
|
1.0
|
N
|
B:LYS117
|
4.5
|
58.9
|
1.0
|
N
|
B:PHE116
|
4.6
|
57.2
|
1.0
|
C
|
B:LYS117
|
4.9
|
59.8
|
1.0
|
CB
|
B:PHE116
|
4.9
|
54.4
|
1.0
|
CG
|
B:ASP118
|
4.9
|
70.0
|
1.0
|
CD1
|
B:PHE116
|
5.0
|
58.7
|
1.0
|
|
Reference:
J.F.Andersen,
H.Lei,
E.C.Strayer,
V.Pham,
T.Kanai,
I.M.Francischetti,
G.F.Gerber,
X.Z.Pan,
O.A.Asojo,
P.H.Alvarenga,
R.A.Brodsky,
J.G.Valenzuela,
J.M.Ribeiro.
A Bifunctional Inhibitor of Complement and Coagulation To Be Published.
Page generated: Thu Jul 11 05:06:58 2024
|